35 High pathologic complete remission rate with liposome-encapsulated doxorubicin + paclitaxel + trastuzumab as primary treatment in HER-2 positive operable breast cancer: clinical experience
J. Gavila, A. Guerrero-Zotano, M.A. Climent, S. Blanch, V. Guillem, J. Camp, M.I. Tortajada, F. Gozalbo, P. Vidal, A. RuizVolume:
8
Year:
2010
Language:
english
DOI:
10.1016/s1359-6349(10)70066-5
File:
PDF, 65 KB
english, 2010